Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03829111
What this trial is testing

CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer

Who this might be right for
Advanced Renal Cell CarcinomaClear Cell Renal Cell CarcinomaMetastatic Renal Cell Carcinoma+3 more
City of Hope Medical Center 30
Testing effectiveness (Phase 2)WithdrawnNCT01176500
What this trial is testing

A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors

Who this might be right for
Colon CancerLung CancerCervical Cancer+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT00030888
What this trial is testing

UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of California, San Francisco
Not applicableUnknownNCT05534854
What this trial is testing

Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes

Who this might be right for
Renal Tumor HistologyKidney CancerRenal Cell Carcinoma+11 more
RenJi Hospital 500
Large-scale testing (Phase 3)Active Not RecruitingNCT03055013
What this trial is testing

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

Who this might be right for
Metastatic Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v7+2 more
National Cancer Institute (NCI) 819
Not applicableStudy completedNCT00957424
What this trial is testing

Acceptability of Less Harmful Alternatives to Cigarettes

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Roswell Park Cancer Institute 67
Early research (Phase 1)Active Not RecruitingNCT02293980
What this trial is testing

A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)

Who this might be right for
ccRCCRCCKidney Cancer+2 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 110
Testing effectiveness (Phase 2)WithdrawnNCT01070186
What this trial is testing

Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Jonsson Comprehensive Cancer Center
Not applicableNot Yet RecruitingNCT05941169
What this trial is testing

Primary Metastatic Renal Cell Carcinoma Treated With Immunecheckpoint Inhibitors and Cytoreductive Nephrectomy

Who this might be right for
Renal Cell Carcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 750
Testing effectiveness (Phase 2)Study completedNCT00006483
What this trial is testing

Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung

Who this might be right for
Kidney CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 27
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Testing effectiveness (Phase 2)UnknownNCT01791387
What this trial is testing

1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Auckland District Health Board 30
Testing effectiveness (Phase 2)UnknownNCT05798455
What this trial is testing

Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Tabriz University of Medical Sciences 30
Testing effectiveness (Phase 2)Study completedNCT01157091
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
City of Hope Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT01058538
What this trial is testing

A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumours
Philogen S.p.A. 33
Testing effectiveness (Phase 2)Study completedNCT02639182
What this trial is testing

AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Astellas Pharma Global Development, Inc. 133
Testing effectiveness (Phase 2)UnknownNCT01041482
What this trial is testing

A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Chinese Academy of Medical Sciences 140
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Not applicableStudy completedNCT02809404
What this trial is testing

Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study)

Who this might be right for
Breast CancerRenal Cell Carcinoma
Radboud University Medical Center 75
Not applicableActive Not RecruitingNCT07697417
What this trial is testing

Multimodal Prediction of Postoperative Prognosis After Partial Nephrectomy for Endophytic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaKidney NeoplasmsEndophytic Renal Tumor+2 more
Tianjin Medical University Second Hospital 406
Next Page